The global brain computer interface market size was valued at USD 1.2 billion in 2019 and is anticipated to register a CAGR of 15.5% over the forecast period. Key drivers of the market for brain computer interface (BCI) technology include increasing prevalence of neuroprosthetic conditions, growing geriatric population, and rising technological developments facilitating communication and movement in paralytic patients. Furthermore, the use of BCI technology in virtual gaming, home control systems, and military communication enhances the applicability of brain computer interface systems, thereby fueling its growth.
Increasing prevalence of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease and epilepsy are expected to drive the demand for brain-computer interface over the forecast period. According to a WHO report, around 82 million people will be affected by dementia by 2030 and this would reach 152 by 2050. This indicates the potential demand for BCI in the coming years.
Brain computer interface technology is increasingly used in mobile and virtual gaming industries by integrating BCI within virtual reality (VR) headsets. Virtual gaming has opened a plethora of new opportunities for mind-controlled headsets and gadgets, which is further driving the adoption of brain-controlled interface technology. Manufacturers are focusing on the development of BCI-enabled video games. For instance, in March 2019, Valve planned to launch games using BCI technology. Innovations such as these are anticipated to drive the market for brain-controlled computer interface technology over the forecast period.
Brain-computer interface systems are optimally suited for the control of smart home applications with its high accuracy and reliability. Home control systems include an application of P300-based technology-an event-related potential component which helps in decision making-for the purpose of carrying out various activities such as opening and closing doors and windows, switching the lights on and off, controlling the TV set and music system, and operating security video cameras. The aforementioned factors are expected to increase the demand for brain computer interface systems in the coming years.
Increasing global geriatric population is another factor driving the BCI market. According to the U.S. Census Bureau, there were more than 52 million people aged 65 and above in the U.S. alone in 2018, which is anticipated to double by 2060. The rising geriatric population is expected to increase the susceptibility of chronic conditions such as diabetes, cardiovascular disorders, and sleep disorders, thereby driving the demand for BCI technology in the coming years.
On the basis of product, the BCI market has been segmented into invasive, partially invasive, and non-invasive BCI. Non-invasive BCI held the largest share in 2019 owing to the high applicability of this technology for products such as headsets, amplifiers, and gaming sticks. Non-invasive brain-computer interface system is considered to be the safest as the approach is less intrusive, which is further fueling the segment growth. In addition, numerous research projects are being conducted in this field. For instance, in June 2019, Carnegie Mellon University, in collaboration with the University of Minnesota, developed the first mind-controlled robotic arm using BCI technology which can track and follow a computer cursor.
Invasive BCI is expected to witness lucrative growth over the forecast period owing to the ability of this BCI technology in providing functionality to paralyzed people through brain-controlled robotic legs and arms.
Partially invasive BCI is also expected to register a significant growth rate over the forecast period owing to its tremendous technological advancement and easy adaptability. For instance, in September 2019 Synchron Inc. launched the trial of Stentrode, a partially invasive neural brain-to-computer interface technology to wirelessly record brain activities.
Healthcare dominated the brain computer interface market in 2019 owing to the high applicability of brain-computer interface technology for the treatment of sleep disorders and neurological diseases. Moreover, BCI technology is increasingly used while treating paralytic patients and for the study of neuroscience.
Moreover, technological advancements and increasing initiatives by key industry players are driving the market for brain computer interface systems. For instance, in June 2018, Medtronic launched a new clinician programmer for deep brain stimulation therapy with Activa neurostimulator. Moreover, in October 2018, Advanced Brain Monitoring Inc. received a grant from the National Institute on Aging to use brain activity biomarkers to prevent cognitive decline associated with aging and dementia. Initiatives such as these are contributing toward the wide application of brain-computer interface systems in healthcare applications.
BCI technology in smart home control is projected to witness lucrative growth over the forecast period due to the rapid development of improved lifestyles. BCI technology in smart home controls provides consumers with added convenience and better control of security monitoring and operating entertainment systems and appliances. Associated benefits of brain-computer interface technology for smart home control systems, especially for people with special needs, is expected to drive the segment growth over the forecast period.
On the basis of end users, the market for BCI has been segmented into medical, military, and others. The medical segment dominated the market in 2019 owing to the significant role BCI technology plays in assisting disabled patients. BCI assists in the movement of patients suffering from diseases such as Parkinsonism, epilepsy, paralysis, and Alzheimer’s disease to independently carry out activities such as operating wheelchairs and prosthetics.
The military segment is expected to witness lucrative growth over the forecast period owing to the increased use of brain-computer interface during war activities. Development of mobile robots that can function as weapon-equipped drones in war zones and advanced communication systems such as Defense Advanced Research Projects Agency’s (DARPA) “Silent Talk”, which would enable soldiers and military personnel to give commands via telepathic communication, are anticipated to contribute to growth of this segment.
North America dominated the market for brain-computer interface in 2019, primarily due to high R&D investments and a large number of clinical trials being conducted on brain devices in the region. In addition, rising incidences of neurodegenerative conditions such as Parkinson's, Alzheimer's, and Huntington's disease are expected to propel the regional market growth. Rising demand for immersive gaming is expected to lead to the development of technologies such as augmented brain computer interface, which would further boost the adoption of BCI technology in the region.
Asia Pacific is expected to exhibit the highest growth rate over the forecast period. Significant untapped opportunities, increasing healthcare expenditure, and growing awareness amongst patients are expected to drive the demand for brain computer interface in this region. Moreover, low-cost manufacturing sites and favorable taxation policies in this region have attracted foreign players to invest in this lucrative market. Intensive R&D for BCI systems led to the launch of several innovative products. For instance, in May 2018, Compumedics collaborated with a China-based organization, Health 100, in order to improve its product portfolio in sleep technology.In March 2019, Integra received approval for DuraGen Dural Regeneration Matrix in Japan, which helped the company expand its presence.
Key market players include Natus Medical, Mind Solutions, Compudemics, Emotiv Incorporation, and Neurosky. The various small and large manufacturers present in the market result in intense competition among manufacturers.
Major players are focusing on strategies such as mergers, acquisitions, new product launches, partnerships, and collaborations to increase their market share. In September 2018, Medtronic acquired Mazor Robotics to improve its robotic surgery portfolio. In October 2017, Natus Medical acquired the neurosurgery business assets of Integra Lifesciences in order to gain a market share in the neurosurgery space.
Report Attribute |
Details |
Market size value in 2020 |
USD 1390.49 million |
Revenue forecast in 2027 |
USD 3.7 billion |
Growth Rate |
CAGR of 15.5% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Revenue in USD million and CAGR from 2020 to 2027 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, end-use, region |
Regional scope |
North America; Europe; APAC; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; India; China; Brazil; Mexico; South Africa; Saudi Arabia |
Key companies profiled |
Natus Medical; Mind Solutions; Compudemics; Emotiv Incorporation; Neurosky |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2027. Grand View Research has segmented the global brain computer interface market report on the basis of product, application, end-use, and region:
Product Outlook (Revenue, USD Million, 2016 - 2027)
Invasive BCI
Partially invasive BCI
Non-invasive BCI
Application Outlook (Revenue, USD Million, 2016 - 2027)
Healthcare
Disabilities Restoration
Brain Function Repair
Smart Home Control
Communication and Control
Entertainment and Gaming
End-use Outlook (Revenue, USD Million, 2016 - 2027)
Medical
Military
Others
Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
The U.S.
Canada
Europe
The U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East and Africa
South Africa
Saudi Arabia
b. The global brain computer interface market size was estimated at USD 1247.08 million in 2019 and is expected to reach USD 1390.49 million in 2020.
b. The global brain computer interface market is expected to grow at a compound annual growth rate of 11.50% from 2019 to 2026 to reach USD 2671.89 million by 2026.
b. North America dominated the brain computer interface market with a share of 39.70% in 2019. This is attributable to high R&D investments and a large number of clinical trials being conducted on brain devices in the region coupled with rising incidences of neurodegenerative conditions such as Parkinson's, Alzheimer's, and Huntington's disease.
b. Some key players operating in the brain computer interface market include Natus Medical, Mind Solutions, Compudemics, Emotiv Incorporation, and Neurosky.
b. Key factors that are driving the brain computer interface market growth include increasing prevalence of neuroprosthetic conditions, growing geriatric population, and rising technological developments facilitating communication and movement in paralytic patients.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.